—

Tempus AI, Inc. Class A Common Stock(TEM)— 同業公司組

數據截至2026-10-30 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Tempus AI, Inc. Class A Common Stock的Closelook綜合評分為41/100,在同業公司組內排名第9位(共9家)——組內評分最高的是BB Biotech AG(74/100)。

名稱綜合動能品質估值訊號距52週高點
TEM Tempus AI, Inc. Class A Common Stock41871915bear30.8%
HQY HealthEquity Inc62757041ok4.8%
VEEV Veeva Systems Inc Class A60957528bull4%
HNGE Hinge Health, Inc.56976322ok2.7%
BTSG BrightSpring Health Services, Inc. Common Stock51812738ok9.3%
BION.SW BB Biotech AG74719681info10%
HALO Halozyme Therapeutics Inc73989439ok2.3%
ONC BeiGene, Ltd.65866431ok4.7%
DXCM DexCom Inc65738040watch11.1%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-30

Quick answers

Tempus AI, Inc. Class A Common Stock在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:HealthEquity Inc (HQY)、Veeva Systems Inc Class A (VEEV)、Hinge Health, Inc. (HNGE)、BrightSpring Health Services, Inc. Common Stock (BTSG)、BB Biotech AG (BION.SW)、Halozyme Therapeutics Inc (HALO)、BeiGene, Ltd. (ONC)、DexCom Inc (DXCM)。

TEM相對同業公司的評分如何?

Tempus AI, Inc. Class A Common Stock的綜合評分為41/100,組內排名第9位(共9家),截至2026-10-30;組內最高綜合評分為BB Biotech AG(74/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.